Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope

被引:20
作者
Lallos, LB
Laal, S
Hoxie, JA
Zolla-Pazner, S
Bandres, JC
机构
[1] NYU, Sch Med, Manhattan VA Med Ctr, Res Ctr AIDS & HIV Infect, New York, NY 10010 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA
[3] Univ Penn, Dept Hematol Oncol, Philadelphia, PA 19104 USA
[4] NYU, Sch Med, Dept Med, New York, NY 10010 USA
关键词
D O I
10.1089/088922299310601
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Both HIV-1 primary isolates and laboratory strains incorporate cell-derived molecules into their envelopes depending on the host cell in which they are grown, This incorporation is not random and, specifically, HIV-1 has been shown to select against the incorporation into its surface of CD4, its main receptor, In this study, we have looked at the incorporation of HIV coreceptors CXCR4, CCR5, and CCR3 into the HIV envelope. For this purpose, we grew HIV-1 primary isolate BZ167 in several cell lines and PBMCs, and the envelope profiles of the resulting viruses were determined with a virus-binding ELISA, While the virus particle gained several molecules when passed through the different cell lines (e.g., ICAM-3, LFA-1, ICAM-1, or MHC class II), BZ167 never incorporated significant levels of CXCR4, CCR5, or CCR3 into its envelope even though some or all of the cell lines in which it was grown expressed them. These results show that HIV-1 selects against the incorporation of these chemokine receptors into its envelope molecule, as it does against the incorporation of CD4.
引用
收藏
页码:895 / 897
页数:3
相关论文
共 13 条
[1]  
AIKHATIB G, 1996, SCIENCE, V272, P1955
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]   Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions [J].
Bastiani, L ;
Laal, S ;
Kim, M ;
ZollaPazner, S .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3444-3450
[4]   The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity [J].
Cantin, R ;
Fortin, JF ;
Lamontagne, G ;
Tremblay, M .
JOURNAL OF VIROLOGY, 1997, 71 (03) :1922-1930
[5]   The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific [J].
Cantin, R ;
Fortin, JF ;
Tremblay, M .
VIROLOGY, 1996, 218 (02) :372-381
[6]   A SIMPLE AND RELIABLE METHOD TO DETECT CELL-MEMBRANE PROTEINS ON INFECTIOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES [J].
CAPOBIANCHI, MR ;
FAIS, S ;
CASTILLETTI, C ;
GENTILE, R ;
AMEGLIO, F ;
DIANZANI, F .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) :886-889
[7]   CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4 [J].
Endres, MJ ;
Clapham, PR ;
Marsh, M ;
Ahuja, M ;
Turner, JD ;
McKnight, A ;
Thomas, JF ;
StoebenauHaggarty, B ;
Choe, S ;
Vance, PJ ;
Wells, TNC ;
Power, CA ;
Sutterwala, SS ;
Doms, RW ;
Landau, NR ;
Hoxie, JA .
CELL, 1996, 87 (04) :745-756
[8]   HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor [J].
Feng, Yu ;
Broder, Christopher C. ;
Kennedy, Paul E. ;
Berger, Edward A. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (11) :872-877
[9]   Acquisition of host cell-surface-derived molecules by HIV-1 [J].
Frank, I ;
Stoiber, H ;
Godar, S ;
Stockinger, H ;
Steindl, F ;
Katinger, HWD ;
Dierich, MP .
AIDS, 1996, 10 (14) :1611-1620
[10]   PRODUCTION OF SITE-SELECTED NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES AGAINST THE 3RD VARIABLE DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN [J].
GORNY, MK ;
XU, JY ;
GIANAKAKOS, V ;
KARWOWSKA, S ;
WILLIAMS, C ;
SHEPPARD, HW ;
HANSON, CV ;
ZOLLAPAZNER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3238-3242